AUG 30, 2020 4:00 AM PDT

Brown Fat Transplants Could Reduce Metabolic Disease

WRITTEN BY: Carmen Leitch

The Centers for Disease Control and Prevention (CDC) estimates that in 2018, obesity impacted about 42 percent of American adults. People with obesity are at higher risk for many diseases, including type 2 diabetes, coronary heart disease, and stroke; they also tend to generally have a lower quality of life and a higher risk of death. As of 2008, obesity was thought to cost the United States about $147 billion a year. All this makes obesity an intense focus of research studies.

Scientists are now learning more about how the different types of fat in the human body are involved in metabolic disease. It's known that brown fat cells work to burn energy, instead of storing it as white fat cells do. If there was a way to add brown fat or convert white fat into brown fat it could help reduce the prevalence of obesity.

Researchers have now developed a way to genetically modify human white fat cells with CRISPR technology so they are more similar to brown fat cells. These HUMBLE (human brown-like) fat cells that generate heat instead of storing energy could then be transplanted into patients with obesity as a therapeutic, said Yu-Hua Tseng, Ph.D., a senior investigator in Joslin Diabetes Center's Section on Integrative Physiology and Metabolism. Tseng is the senior author of the report on this work in Science Translational Medicine.

These newly-transplanted brown fat cells would then theoretically be able to reduce the levels of excess glucose and lipids in the blood, which is a characteristic of metabolic diseases like diabetes. People that are overweight or obese often have less beneficial brown fat, and the HUMBLE cells can help them overcome this problem, Tseng said.

The HUMBLE cells were made by using human white fat cells that are not fully differentiated; they are in a progenitor state and not in their final form. With CRISPR-Cas9, the researchers raised the expression of a gene called UCP1 to cause the progenitor white fat cells to become like brown fat cells.

The scientists transplanted these cells into a mouse model that lacked an immune system, reducing the likelihood of rejection, and the cells seemed to function like brown fat cells. Mice with the transplanted cells had greater sensitivity to insulin and were better at removing glucose from their blood, and they gained less weight than mice that had received transplanted white cells.

Fat tissue is shown in top panels, bottom panels show hUCP1 (red), only found in brown fat cells. HUMBLE fat cells are similar to white fat cells but express the brown fat-specific hUCP1 protein. / Credit: Joslin Diabetes Center

The scientists found that any health benefits were primarily due to transplanted cells to signaling to existing brown fat cells in the mice. "Cells in different tissues communicate with each other," Tseng said. "In this case, we found that our transplanted HUMBLE cells secrete a molecule called nitric oxide, which is carried by red blood cells to the endogenous brown cells and activates those cells."

This therapy is not ready for the clinic, but Tseng is hopeful that if it works in pre-clinical studies, it may one day be possible to apply this technique to individual patients. In that process, a small number of cells would be removed from a patient, isolated and modified, then returned to the patient as HUMBLE cells. Tseng's team is also interested in a more generally applicable and less costly approach. For example, it may be possible to use generic cells that are not removed from the patient, by coating them in a material that would protect them from the immune system.

"Employing cell-based or gene therapies to treat obesity or type 2 diabetes used to be science fiction," she says. "Now scientific advances, such as CRISPR gene-editing technologies, will help us to improve the metabolism, the body weight, the quality of life, and the overall health of people with obesity and diabetes."


Sources: AAAS/Eurekalert! via Joslin Diabetes Center, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUL 24, 2020
Immunology
Telling the Difference Between Eczema and Psoriasis
JUL 24, 2020
Telling the Difference Between Eczema and Psoriasis
It can be extremely different even for professionals to tell the difference between psoriasis, an autoimmune disorder, a ...
JUL 27, 2020
Plants & Animals
Why Mosquitoes Have a Preference for Human Blood
JUL 27, 2020
Why Mosquitoes Have a Preference for Human Blood
There is a huge variety of mosquitoes in the world - around 3,500 species - and only a few seek humans for their blood m ...
AUG 23, 2020
Genetics & Genomics
Genetically Engineered Mosquitoes Will be Released in Florida
AUG 23, 2020
Genetically Engineered Mosquitoes Will be Released in Florida
After years of development, testing, and regulatory approvals, a genetically engineered mosquito will be released in Flo ...
SEP 27, 2020
Genetics & Genomics
There's More to the Y Chromosome Than We Knew
SEP 27, 2020
There's More to the Y Chromosome Than We Knew
While humans beings carry mostly the same genes on two copies of 23 chromosomes, the sex chromosomes are a bit different ...
SEP 30, 2020
Genetics & Genomics
Not All Vikings Were Scandinavian, New Genetic Research Shows
SEP 30, 2020
Not All Vikings Were Scandinavian, New Genetic Research Shows
Genetic research has upended what we thought was true of Vikings. These seafaring invaders left archeological sites thro ...
OCT 18, 2020
Genetics & Genomics
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
OCT 18, 2020
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
The pandemic virus SARS-CoV-2 is thought to have originated in bats, like many viruses. To make the leap and infect anot ...
Loading Comments...